OICS v0.3.3 class · Healthcare

Branded Prescription Drugs

ID RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies241 Listed with filings161

Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company	Ticker	Country	Market cap	Filings
Synthaverse S.A.	BML	Poland	—	397
Everest Medicines Limited	1952	Cayman Islands	—	376
DRI Healthcare Trust	DHT.UN	Canada	—	372
Merck Tbk	MERK	Indonesia	—	365
HK inno.N Corporation	195940	South Korea	—	352
Abbott Laboratories (Pakistan) Limited	ABOT	Pakistan	—	326
Nippon Shinyaku Co.,Ltd.	4516	Japan	—	289
Chemical Works of Gedeon Richter Plc	RICHT	Hungary	—	244
KOREA PHARMA Co., Ltd.	032300	South Korea	—	244
Hangzhou Jiuyuan Gene Engineering Co., Ltd.	2566	Hong Kong	—	163
LUYE PHARMA GROUP LTD.	1M4B	Singapore	—	153

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

big pharmainnovative pharmaceuticalsanimal health

Not here

no approved product → CLB Clinical-Stage Biotech
approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Sent here from

Other classes in Pharmaceuticals

Generics & Consumer Health GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Also generics, OTC, API manufacturer, biosimilars

Not here makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
Not here mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Permanent link

https://financialfilings.com/oics/RXB/

This page is keyed by the class ID RXB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard